首页> 美国卫生研究院文献>Molecular and Clinical Oncology >Clinical characteristics and prognostic analysis of triple-negative breast cancer patients
【2h】

Clinical characteristics and prognostic analysis of triple-negative breast cancer patients

机译:三阴性乳腺癌患者的临床特征和预后分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is well-established that triple-negative breast cancer (TNBC) is a subtype of breast cancer, characterized by a poor prognosis and aggressive biological behavior. However, the available relevant data on TNBC in non-Western populations are limited. In order to analyze the clinicopathological and molecular biological characteristics and observe survival and prognostic factors, 972 breast cancer patients (156 of whom had TNBC) who received treatment at the First Affiliated Hospital of Medical School of Xi'an Jiaotong University and the First Hospital of China Medical University, between January, 2004 and January, 2007 were retrospectively evaluated. In the univariate analysis, tumor size, TNM stage, axillary lymph node status and recurrence or metastasis were identified as prognostic factors for 7-year disease-free survival (DFS) and overall survival (OS). Our multivariate Cox's regression analysis demonstrated that tumor size and axillary lymph node status were significant prognostic factors for 7-year DFS and OS. Notably, tumor subgroup (TNBC vs. non-TNBC) was a significant prognostic factor associated with 7-year DFS and OS in breast cancer. It was suggested that TNBC exhibited a worse 7-year survival compared with that in non-TNBC patients, most likely due to its more aggressive behavior and insensitivity to specific therapy.
机译:众所周知,三阴性乳腺癌(TNBC)是乳腺癌的一种亚型,其预后不良和生物学行为具有侵袭性。但是,非西方人口中有关TNBC的可用相关数据有限。为了分析临床病理和分子生物学特征并观察生存和预后因素,在西安交通大学医学院附属第一医院和上海第一医院接受治疗的972例乳腺癌患者(其中156例患有TNBC)。对2004年1月至2007年1月的中国医科大学进行回顾性评估。在单变量分析中,肿瘤大小,TNM分期,腋窝淋巴结状态和复发或转移被确定为7年无病生存期(DFS)和总体生存期(OS)的预后因素。我们的多变量Cox回归分析表明,肿瘤大小和腋窝淋巴结状态是7年DFS和OS的重要预后因素。值得注意的是,肿瘤亚组(TNBC与非TNBC)是与乳腺癌7年DFS和OS相关的重要预后因素。提示与非TNBC患者相比,TNBC的7年生存期较差,这很可能是由于其更具攻击性的行为以及对特定疗法的不敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号